Floatz logo

gc1111

Mucopolysaccharidosis (MPS)

TakedaPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Mucopolysaccharidosis (MPS) cohort.

Asset / SponsorPhaseRating
.BETA.-GLUCURONIDASE (SYNTHETIC HUMAN), HOMOTETRAMER
Ultragenyx Pharmaceutical Inc
Phase 3BBB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Takeda
Phase 4BB
METHOTREXATE
Takeda
Phase 4BB
HUMAN IMMUNOGLOBULINS
Takeda
Phase 4B
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 13 →

Same molecule, other indications

gc1111 is also rated in:

mucopolysaccharidosis type 2Dormant
A
Indicative ·
86 / 100
View asset →
mucopolysaccharidosis type 2Dormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →